Yew Bio-Pharm Group, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was USD 10.355 million compared to USD 667,526 a year ago. Operating income was USD 1.494 million compared to USD 1.072 million a year ago. Net income was USD 995,974 compared to USD 1.183 million a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago. For the nine months, total revenue was USD 21.946 million compared to USD 24.746 million a year ago. Operating income was USD 2.508 million compared to USD 2.753 million a year ago. Net income was USD 1.884 million compared to USD 2.997 million a year ago. Basic earnings per share from continuing operations was USD 0.04 compared to USD 0.06 a year ago.